Titan Pharmaceuticals, Inc.
General ticker "TTNP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $4.0M (TTM average)
Titan Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 11.8%.
Estimated limits based on current volatility of 3.4%: low 3.18$, high 3.40$
Factors to consider:
- Total employees count: 4 (0.0%) as of 2023
- Top business risk factors: Insufficient funding, Product development delays, Product liability, Regulatory and compliance, Economic downturns and volatility
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.75$, 5.48$]
- 2025-12-31 to 2026-12-31 estimated range: [1.21$, 3.84$]
Financial Metrics affecting the TTNP estimates:
- Positive: with PPE of -0.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -127.10 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Inventory ratio change, % of 92.31 > 0.84
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Shareholder equity ratio, % of 83.48 > 63.39
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term TTNP quotes
Long-term TTNP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.06MM | $0.00MM | $0.00MM |
| Operating Expenses | $10.29MM | $7.28MM | $4.56MM |
| Operating Income | $-10.23MM | $-7.28MM | $-4.56MM |
| Non-Operating Income | $0.03MM | $1.71MM | $-0.15MM |
| R&D Expense | $4.76MM | $1.91MM | $0.00MM |
| Income(Loss) | $-10.21MM | $-5.57MM | $-4.71MM |
| Profit(Loss)* | $-10.18MM | $-5.57MM | $-4.71MM |
| Stockholders Equity | $1.36MM | $6.64MM | $2.44MM |
| Inventory | $0.11MM | $0.00MM | $0.00MM |
| Assets | $4.06MM | $8.09MM | $2.92MM |
| Operating Cash Flow | $-8.18MM | $-7.09MM | $-3.88MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $0.73MM | $0.00MM |
| Financing Cash Flow | $4.98MM | $10.00MM | $-0.06MM |
| Earnings Per Share** | $-15.15 | $-7.41 | $-5.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.